Resources and Support - RUCONEST Treatment for HAE Attacks

Ruconest solutions. Expertise. Delivered personally.

Individualized support that your patients with HAE can count on

At Pharming Healthcare, our priority is making sure your patients have access to their prescribed acute HAE therapy and know how to use it. RUCONEST SOLUTIONS offers support that's tailored to meet the individual needs of patients prescribed RUCONEST to treat their HAE attacks.

RUCONEST SOLUTIONS offers services that not only help patients get started with therapy, but also supports them throughout their RUCONEST journey. Additional highlights of the program include:

Program Availability

Program availability to your consented patients, whether they are newly diagnosed or have been living with HAE for years.

Dedicated Patient Team

A team of dedicated individuals who are skilled in navigating HAE coverage, access, educational and training needs for you and your patients.

Support Programs

Services to help you and your patients get started with RUCONEST and ongoing support along the way.

Get your patients started by downloading our enrollment form here.

It's easy for patients to get started on RUCONEST with individualized support

RUCONEST SOLUTIONS is designed to provide tailored support through a team of dedicated nurses who will work to identify and support your patients' needs. As registered nurses, they can help facilitate HAE access-related needs by:

Providing self-administration training at your patients’ convenience in the comfort of their home
Developing an individualized Emergency Care Plan
Identifying alternate infusion locations as needed
Securing on-demand home-infusion services for patients who are not able to self-administer, RUCONEST SOLUTIONS will work with your office to secure an on-demand nurse
Training on appropriate vein care to help support long-term self-administration of RUCONEST

Continuous support with RUCONEST SOLUTIONS

Every RUCONEST SOLUTIONS team member understands the complexities of living with HAE and is committed to each of their patients and the HAE community through dedicated support. They are available for any questions your patients may have and will follow up with them to ensure they have everything they need.

RUCONEST SOLUTIONS is available from 8 AM to 8 PM Eastern Time—Monday through Friday—to answer any questions about HAE and RUCONEST.

For more information, call 1-855-613-4HAE (4423)

^a Conversations with RPAs are not intended to replace discussions with a healthcare provider.

^b Availability subject to geographic location.

RUCONEST StarterRx

We understand that it may take time to confirm coverage for a new HAE therapy. Patients new to RUCONEST therapy may be eligible to receive up to 2 doses of RUCONEST to begin their treatment.^c During this time, we will work with your office and your patient’s insurance company to help get RUCONEST covered. If your patient is having payer access-related delays, and they have already utilized their RUCONEST StarterRx, they may be eligible for the Bridge to Therapy Program to avoid a gap in therapy.
Once you complete the RUCONEST SOLUTIONS Patient Enrollment and Patient Authorization Forms, our team will coordinate with your patients to determine the best date and time for self-injection training. RPAs will train your patient as many times as needed, until they are comfortable administering RUCONEST on their own. ^d

RUCONEST Coverage Assistance

RUCONEST SOLUTIONS may offer copay support to eligible patients. Coverage assistance may be available to patients who meet the predefined eligibility criteria (i.e., HAE diagnosis, etc.) to help with costs associated with RUCONEST therapy.
Patients who do not qualify for RUCONEST programs may be referred to external assistance programs.

To learn more about the RUCONEST Patient Assistance Program, please call us at 1-855-613-4HAE (4423).

^c Patients new to RUCONEST may be eligible for a trial (up to 2 doses). Offer is subject to modification or cancellation at any time, with or without notice.

^d Patients must be consented in order to benefit from the patient support services.

Pharming Healthcare, Inc. does not have any obligation to provide the program services to patients and is not liable in the provision of these services.

If your patient does not have insurance or insurance for RUCONEST, we may be able to help your patient find a program that fits based on eligibility or availability.

Before your patients can enroll in the patient assistance program, it is important they understand that they will be asked to provide personal information that may include their name, address, phone number, email address, financial information, and information related to their prescription medication insurance and treatment. This information will be used by Pharming Healthcare, Inc., and its service providers to determine their eligibility for, enroll them in, and administer the program.

Offer good only in the United States and its territories. Void where prohibited, taxed, or limited by law. Program terms will expire at the end of each calendar year and may change or end without notice, including in specific states.

Some employers, insurers, and other companies require patients to apply for medication coverage from free product programs instead of covering such medications directly and immediately through insurance, which could lead to delays in care. These types of “Assistance Diversion Programs” are generally established by companies that profit by diverting resources away from patients in need. An Assistance Diversion Program is any insurer, employer, or third-party program that withholds coverage or payment for patient’s medically necessary drug until patient has completed an application for free product assistance.

If your patient’s employer, insurer, or any other Assistance Diversion Program or company mandates that they apply, maximize, exhaust, and/or show proof of denial in a manufacturing’s assistance program, they are not eligible for Pharming’s Patient Assistance Program even if they meet all other coverage criteria. Pharming Healthcare, Inc. does not have any obligation to provide the program services to them and is not liable in the provision of these services.

Introduce patients to their dedicated RUCONEST SOLUTIONS Team

Each team is here to help patients and caregivers throughout their treatment journey.

RUCONEST SOLUTIONS Case Manager

Verifies RUCONEST coverage and on boards your patient to program services

RUCONEST Patient Advocate (RPA)*

Help patients and caregivers build the knowledge, skills and confidence to self-administer RUCONEST

Reimbursement Access Director (RAD)

Helps your office and your patients navigate coverage, access and insurance related needs

RUCONEST SOLUTIONS is designed to help provide access-related support once you have decided RUCONEST is the right acute therapy for your patients’ HAE.

^* RUCONEST Patient Advocates (RPAs) are clinical educators who do not provide nursing services, medical advice, or treatment advice. RPAs do not sell, market, or promote RUCONEST.

Every RUCONEST patient advocate understands the complexities of living with HAE and is committed to each patient and the HAE community through in-person or virtual support. They are available for any questions your patients may have and will follow up with them to ensure they have everything they need.

Help Patients find their dedicated RUCONEST Patient Advocate (RPA)

As part of RUCONEST SOLUTIONS, your patients have access to a highly skilled RUCONEST Patient Advocate (RPA). RPAs are clinical nurse educators, who may help your patients and their families build the knowledge and confidence to self-administer RUCONEST.

RPAs can offer flexible availability to assist your patients with outreach and support. If patients haven’t had the opportunity to connect with their RPA yet, they can contact RUCONEST SOLUTIONS at (855) 613-4423 where they will be transferred to their dedicated RPA.

Your RPA can assist with:

Self-administration training at their convenience in the comfort of their home or another location
Developing their individualized Emergency Care Plan
Identifying alternate veins for IV injection to maintain good vein health
Providing many RUCONEST tools and resources to help during their HAE journey
Offering ongoing support and training as needed, as long as your patient requires training and resources

RUCONEST Patient Advocates (RPAs) are Clinical Educators who do not provide nursing services, medical advice, or treatment advice. Clinical Educators do not sell, market, or promote RUCONEST.

RUCONEST Patient Advocate (RPA) Search Tool

Enter 5 Digit ZipCode

Interested in getting in touch with your RPA? Please contact your Case Manager at 855-613-4423 and have them transfer you to your dedicated advocate.

Reimbursement Access Director (RAD) helps patients navigate access

RADs can help your office and patients navigate any RUCONEST related insurance coverage and access questions or issues.

They are also a dedicated resource who are able to assist patient with resources, information, and education when additional continuation of therapy support is needed.

Please Select State or Territory

You may contact your Case Managers by calling RUCONEST SOLUTIONS at (855) 613-4423.

Get access to RUCONEST in 3 easy steps

Identify Patient
Download and Fill Out the Patient Enrollment Form here
Fax form to RUCONEST SOLUTIONS at 855-423-5757.

Terms and Conditions

Your Patient Consent form is required before you can access RUCONEST SOLUTIONS support services, which includes Starter Rx and access to an RPA.

Some programs are limited to patients with commercial insurance.

The program only applies in the United States, including Puerto Rico and other US territories, and does not apply where prohibited by state law or other restrictions. Program is subject to availability, and Pharming Healthcare Inc. reserves the right to rescind, revoke or amend the Program at any time without notice.

If your insurance company is impacted by an Accumulator and/or a Maximizer program, this can impact program eligibility. Click to Learn More.

WHAT IS RUCONEST?

RUCONEST® (C1 esterase inhibitor [recombinant]) is indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE). Effectiveness in clinical studies was not established in HAE patients with laryngeal attacks.

IMPORTANT SAFETY INFORMATION

RUCONEST is contraindicated in patients with a history of allergy to rabbits or rabbit-derived products and for patients with a history of life-threatening immediate hypersensitivity reactions, including anaphylaxis, to C1 esterase inhibitor (C1-INH) preparations.

Monitor patients for early signs of allergic or hypersensitivity reactions (including hives, generalized urticaria, tightness of the chest, wheezing, hypotension, and/or anaphylaxis). If symptoms occur, discontinue RUCONEST and administer appropriate treatment.

Serious arterial and venous thromboembolic (TE) events have been reported with plasma-derived C1-INH products. Risk factors may include the presence of an indwelling venous catheter/access device, prior history of thrombosis, underlying atherosclerosis, use of oral contraceptives or certain androgens, morbid obesity, and immobility. Monitor patients with known risk factors for TE events during and after RUCONEST administration.

Appropriately trained patients may self-administer RUCONEST upon recognition of an HAE attack. Advise patients to seek medical attention if progress of any attack makes them unable to properly prepare or administer a dose of RUCONEST. No more than 2 doses should be administered within a 24-hour period.

The serious adverse reaction reported in clinical trials was anaphylaxis. The most common adverse reactions (incidence ≥2%) were headache, nausea, and diarrhea.

Before prescribing RUCONEST, please read the full Prescribing Information including the Patient Product Information.